NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-205 Cr | ₹-186 Cr | ₹-119 Cr | ₹11 Cr | ₹-252 Cr |
What is the latest Cash Flow from Financing Activities ratio of NECTAR LIFESCIENCES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-205 Cr |
Mar2023 | ₹-186 Cr |
Mar2022 | ₹-119 Cr |
Mar2021 | ₹11 Cr |
Mar2020 | ₹-252 Cr |
How is Cash Flow from Financing Activities of NECTAR LIFESCIENCES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-205 Cr | Negative | |
Mar2023 | ₹-186 Cr | Negative | |
Mar2022 | ₹-119 Cr | Negative | |
Mar2021 | ₹11 Cr | Positive | |
Mar2020 | ₹-252 Cr | - |
Compare Cash Flow from Financing Activities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹818.7 Cr | 7.9% | -0.3% | 20.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹435,407.0 Cr | 0.3% | 0.2% | 46% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,489.0 Cr | -2.7% | -0.1% | 58.9% | Stock Analytics | |
CIPLA | ₹117,443.0 Cr | -3% | -8.6% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,338.0 Cr | -0.1% | -3.4% | 7.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,244.9 Cr | 0.8% | 1.8% | 48.1% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | 7.9% |
-0.3% |
20.7% |
SENSEX | 0.7% |
2.5% |
17% |
You may also like the below Video Courses